Diagnostic and Interventional Cardiology

Antiplatelet Plavix (Clopidogrel). OPT-PEACE trial found that nearly all patients receiving antiplatelet therapy developed evidence of abnormal gastrointestinal (GI) mucosal findings on capsule endoscopy. GettyImages

News | Antiplatelet and Anticoagulation Therapies

Most PCI Patients on Antiplatelet Therapy Developed Abnormal Gastrointestinal Findings

November 9, 2021 — Utilizing a magnetically-controlled capsule endoscopy system, the double-blind, randomized OPT-PEACE ...

November 09, 2021

An illustration of the Recor renal denervation ablation balloon at work in the renal artery.. Renal Denervation Recor RDN ablation balloon #TCT2021

News | Hypertension

Renal Denervation Combined With Medication Can Treat Resistant Hypertension

November 9, 2021 — Six-month outcomes from the randomized RADIANCE-HTN TRIO Trial comparing endovascular ultrasound ...

November 09, 2021

$Abbott's fractional flow reserve (FFR) system. #TCT #TCT21 #FAME3$

News | FFR Technologies

FAME 3 Study Finds FFR Guided PCI Did Not Perform as Well at One-year Compared to Bypass Surgery

November 9, 2021 — The primary results of the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation ...

November 09, 2021

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

The Alvimedica Cre8 Evo Cre8 polymer-free amphilimus-eluting stent

News | Stents

Patients With Diabetes Undergoing PCI Have Less Target Lesion Failure With Amphilimus-eluting Stents

November 9, 2021 — Results from SUGAR trial, a randomized, controlled, multicenter trial conducted exclusively in ...

November 09, 2021

TAVR CT image reconstruction of an implanted Medtronic CoreValve. #TCT21 #TCT #TAVR #SURTAVI

News | Heart Valve Technology

Intermediate-risk Patients Have Similar Five-year Outcomes With Transcatheter or Surgical Aortic Valve Replacement

November 9, 2021 — New five-year data from the SURTAVI trial found that there was no difference in all-cause mortality ...

November 09, 2021

A PARTNER 3 trial economic analysis shows for low surgical risk patients, TAVR is cost-saving compared with SAVR. TAVR Sapien Valve visualized using a GE guidance software. #TCT2021

News | Structural Heart

TAVR Is Cost Effective Compared With Surgical Replacement for Low-risk Patients

November 9, 2021 — An economic analysis of data from PARTNER 3, a randomized trial comparing transcatheter aortic valve ...

November 09, 2021

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

News | FFR Technologies

QFR Technology for Advanced Coronary Artery Disease Leads to Improved Outcomes

November 9, 2021 — Use of a novel technique called the quantitative flow ratio (QFR) to precisely identify and measure ...

November 09, 2021

The Cardiologs AI-enabled software being used to remotely monitor a cardiac patient. #Telecardiology, cardiac telehealth

News | Remote Monitoring

Philips Expand Cardiac Diagnostics and Monitoring Portfolio With Cardiologs Acquisition

November 20, 2021 – Philips announced it signed an agreement to acquire Cardiologs, a France-based medical technology ...

November 09, 2021

$Caption Health's AI automated ejection fraction software.$

News | Artificial Intelligence

Caption Health and Ultromics Partner to Wide Availability of AI-enabled Cardiac Ultrasound Tools

November 9, 2021 — Caption Health and Ultromics, developers of artificial intelligence (AI) to improve cardiac ...

November 09, 2021

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

SARS-CoV-2 (COVID-19) virus added to cells. Image from the Institute for Molecular Bioscience, The University of Queensland. Image of the COVID-19 Virus

News | Coronavirus (COVID-19)

Vascular Disease in COVID-19 is Not Caused by Viral Infection of Blood Vessels

November 9, 2021 — The COVID-19 (SARS-CoV-2) virus does not infect blood vessels, despite the high risk of blood clots ...

November 09, 2021

A new large-scale, real-world analysis of Centers for Medicare and Medicaid Services (CMS) outcomes data from of peripheral vascular interventions guided by intravascular ultrasound (IVUS) showed a 32% reduction in major adverse limb events, such as amputations, during lower extremity arterial intervention.

News | Intra-Vascular Ultrasound (IVUS)

IVUS Improved Outcomes in Largest Real-world Analysis of Lower Extremity Peripheral Vascular Interventions

November 9 2021 — A new large-scale, real-world analysis of Centers for Medicare and Medicaid Services (CMS) outcomes ...

November 09, 2021

The two FDA-cleared transcatheter LAA occlusion devices on the U.S. market were compared in the SWISS-APERO and SEAL FLX trials presented at TCT 2021. Left is the Abbott Amulet device, right is the newest generation Watchman FLX device.

News | Left Atrial Appendage (LAA) Occluders

First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

November 8, 2021 – SWISS-APERO is the first randomized clinical trial comparing the Abbott Amulet left atrial appendage ...

November 08, 2021

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

The Edwards Lifesciences Evoque transcatheter tricuspid valve replacement system demonstrated sustained favorable patient outcomes at six months in the TRISCEND study.

News | Structural Heart

Six-Month Outcomes Positive for Transfemoral Tricuspid Valve in Tricuspid Regurgitation Patients

November 8, 2021 — Results from a clinical trial of the Edwards Lifesciences Evoque transcatheter tricuspid valve ...

November 08, 2021

The ControlRad device collimates the area of interest where the physicians are working, and reduces the dose significantly to peripheral areas in the image.

News | Radiation Dose Management

Beaumont Uses New Cardiac Cath Lab Technology to Reduce Radiation Exposure

November 5, 2021 – An FDA-approved device used during cardiac cath lab procedures cut radiation exposure for ...

November 05, 2021

A Johns Hopkins Medicine study of nearly 4,500 patients hospitalized with COVID-19 suggests that statins — medications widely used to control cholesterol — are not helpful in reducing COVID-related mortality or the severity of the illness. Graphic created by M.E. Newman, Johns Hopkins Medicine

News | Coronavirus (COVID-19)

Statins Likely Not Helpful In Reducing COVID Mortality or Severity

November 5, 2021 — In the worldwide effort to battle COVID-19 (SARS-CoV-2), researchers have often turned to medications ...

November 05, 2021